Highly efficient therapeutic gene editing of human hematopoietic stem cellsYuxuan Wu, Daniel E. Bauer, Alessandra Biffi et al.|Nature Medicine|2019Cited by 518
High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosingRobert N. Plasschaert, Chris Mason, Mark P. DeAndrade et al.|Molecular Therapy|2022Cited by 13
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestationsJohn K. Yoon, Niek P. van Til, Jeffrey W. Schindler et al.|Molecular Therapy|2024Cited by 5
Genetically engineered microglia-like cells have therapeutic potential for neurodegenerative diseaseRobert N. Plasschaert, Chris Mason, Mark P. DeAndrade et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 2
High throughput monitoring of safety, potency and stability of gene therapy cell products in lysosomal disease patientsLuca Biasco, Chris Mason, Cristina Baricordi et al.|Molecular Genetics and Metabolism|2022Cited by 0